Advanced SearchSearch Tips
Antifungal Activity of Bee Venom and Sweet Bee Venom against Clinically Isolated Candida albicans
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Journal of Pharmacopuncture
  • Volume 19, Issue 1,  2016, pp.45-50
  • DOI : 10.3831/KPI.2016.19.006
 Title & Authors
Antifungal Activity of Bee Venom and Sweet Bee Venom against Clinically Isolated Candida albicans
Lee, Seung-Bae;
  PDF(new window)
Objectives: The purpose of this study was to investigate the antifungal effect of bee venom (BV) and sweet bee venom (SBV) against Candida albicans (C. albicans) clinical isolates. Methods: In this study, BV and SBV were examined for antifungal activities against the Korean Collection for Type Cultures (KCTC) strain and 10 clinical isolates of C. albicans. The disk diffusion method was used to measure the antifungal activity and minimum inhibitory concentration (MIC) assays were performed by using a broth microdilution method. Also, a killing curve assay was conducted to investigate the kinetics of the anti-fungal action. Results: BV and SBV showed antifungal activity against 10 clinical isolates of C. albicans that were cultured from blood and the vagina by using disk diffusion method. The MIC values obtained for clinical isolates by using the broth microdilution method varied from to for BV and from to for SBV. In the killing-curve assay, SBV behaved as amphotericin B, which was used as positive control, did. The antifungal efficacy of SBV was much higher than that of BV. Conclusion: BV and SBV showed antifungal activity against C. albicans clinical strains that were isolated from blood and the vagina. Especially, SBV might be a candidate for a new antifungal agent against C. albicans clinical isolates.
anti-fungal activity;bee venom;clinical Candida albicans;sweet bee venom;
 Cited by
Odds FC. Candida species and virulence. Am Soc Microbiol News. 1994;60(6):313-8.

Verduyn Lunel FM, Meis JF, Voss A. Nosocomial fungal infections: candidemia. Diagn Microbiol Infect Dis. 1999;34(3):213-20. crossref(new window)

McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Pilkaytis BD, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis. 2001;33(5):641-7. crossref(new window)

Bodey GP. The emergence of fungi as major hospital pathogens. J Hosp Infect. 1988;11(Suppl A):411-26. crossref(new window)

Edwards JE Jr. Invasive candida infections-evolution of a fungal pathogen. N Engl J Med. 1991;324(15):1060-2. crossref(new window)

Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis. 1995;21(4):897-904. crossref(new window)

Edwards JE Jr, Bodey GP, Boeden RA, Buchner T, DePauw BE, Filler SG, et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis. 1997;25(1):43-59. crossref(new window)

Anttila VJ, Ruutus P, Bondestam S, Jansson SE, Nordling S, Farkkila M, et al. Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin Infect Dis. 1994;18(6):979-81. crossref(new window)

Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis. 1990;12(2):308-29. crossref(new window)

Hartsel S, Bolard J. Amphotericin B: new life for an old drug. Trends Pharmacol Sci. 1996;17(12):445-9. crossref(new window)

Matsuoka S, Murata M. Cholesterol markedly reduces ion permeability induced by membrane-bound amphotericin B. Biochim Biophys Acta. 2002;1564(2):429-34. crossref(new window)

Fonos V, Cataldi L. Amphotericin B-induced nephrotoxicity: a review. J Chemother. 2000;12(6):463-70. crossref(new window)

Mayer J, Doubek M, Doubek J, Horky D, Scheer P, Stepanek M. Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study. J Infect Dis. 2002;186(3):379-88. crossref(new window)

Chee HY, Kim H, Lee MH. In vitro antifungal activity of limonene against trichophyton rubrum. Microbiology. 2009;37(3):243-46.

Kwon YB, Lee HJ, Han HJ, Mar WC, Kang SK, Yoon OB, et al. The water-soluble fraction of bee venom produces anti-nociceptive and antiinflammatory effects on rheumatoid arthritis in rats. Life Sci. 2002;71(2):191-204. crossref(new window)

Kim HW, Kwon YB, Ham TW, Rho DH, Yoon SY, Lee JH, et al. Acupoint stimulation using bee venom attenuates formalin induced pain behavior and spinal cord fos expression in rats. J Vet Med Sci. 2003;65(3):349-55. crossref(new window)

Han SM, Lee KG, Yeo JH, Kweon HY, Kim BS, Kim JM, et al. Antibacterial activity of the honey bee venom against bacterial mastitis pathogens infecting dairy cows. Int J Indust Entomol. 2007;14(2):137-42.

Lee SM, Lim J, Lee JD, Choi DY, Lee S. Bee venom treatment for refractory postherpetic neuralgia: a case report. J Altern Complement Med. 2014;20(3):212-4. crossref(new window)

Choi SH, Cho SK, Kang SS, Bae CS, Bai YH, Lee SH, et al. Effect of apitherapy in piglets with preweaning diarrhea. Am J Chin Med. 2003;31(2):321-6. crossref(new window)

Park HJ, Lee SH, Son DJ, Oh KW, Kim KH, Song HS, et al. Anti-arthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-B through interaction with the p50 subunit. Arthritis Rheum. 2004;50(11):3504-15. crossref(new window)

Choi YG, Choi SH, Kwon KR. [Purification of peptide components including melitittin from bee venom using gel filtration chromatography and propionic acid/urea polyacrylamide gel electrophoresis]. J Pharmacopuncture. 2006;9(2):105-11. Korean.

Eiseman JL, Von Bredow J, Alvares AP. Effect of honeybee (Apis mellifera) venom on the course of adjuvant-induced arthritis and depression of drug metabolism in the rat. Biochem Pharmacol. 1982;31(6):1139-46. crossref(new window)

Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Muller U, et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest. 1996;98(7):1676-83. crossref(new window)

Kwon YB, Lee JD, Lee HJ, Han HJ, Mar WC, Kang SK, et al. Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain. 2001;90(3):271-80. crossref(new window)

Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL, et al. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol. 2005;43(8):3884-9. crossref(new window)

Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob Agents Chemother. 1998;42(5):1207-12.

Owens WE, Nickerson SC, Boddie RL, Tomita GM, Ray CH. Prevalence of mastitis in dairy heifers and effectiveness of antibiotic therapy. J Dairy Sci. 2001;84(4):814-7. crossref(new window)

Pitkala A, Haveri M, Pyorala S, Myllys V, Honkanen-Buzalski T. Bovine mastitis in Finland 2001-prevalence, distribution of bacteria, and antimicrobial resistance. J Dairy Sci. 2004;87(8):2433-41. crossref(new window)

Nair MK, Joy J, Vasudevan P, Hinckley L, Hoagland TA, Venkitanarayanan KS. Antibacterial effect of caprylic acid and monocaprylin on major bacterial mastitis pathogens. J Dairy Sci. 2005;88(10):3488-95. crossref(new window)

Komine Y, Komine K, Kai K, Itagaki M, Kuroishi T, Aso H, et al. Effect of combination therapy with lactoferrin and antibiotics against staphylococcal mastitis on drying cows. J Vet Med Sci. 2006;68(3):205-11. crossref(new window)

Fennell JF, Shipman WH, Cole LJ. Antibacterial action of melittin, a polypeptide from the venom. Proc Soc Exp Biol Med. 1968;127(3):707-10. crossref(new window)

Somerfield SD, Stach JL, Mraz C, Gervais F, Skamene E. Bee venom inhibits superoxide production by human neutrophils. Inflammation. 1984;8(4):385-91. crossref(new window)

Saini SS, Peterson JW, Chopra AK. Melittin binds to secretory phospholipase A2 and inhibits its enzymatic activity. Biochem Biophys Res Commun. 1997;238(2):436-42. crossref(new window)

Stocker JF, Traynor JR. The action of various venoms on Escherichia coli. J Appl Bacteriol. 1986;61(5):383-8. crossref(new window)

Perumal Samy R, Gopalakrishnakone P, Thwin MM, Chow TK, Bow H, Yap EH, et al. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes. J Appl Microbiol. 2007;102(3):650-9. crossref(new window)

Nakatuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, et al. Antimicrobial property of lauric acid against Propionibacterium acnes: Its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol. 2009;129(10):2480-8. crossref(new window)

Han SM, Lee KG, Yeo JH, Baek HJ, Park KK. Antibacterial and anti-inflammatory effects of honeybee (Apis mellifera) venom against acne-inducing bacteria. J Med Plants Res. 2010;4(6):459-64.

Yu AR, Kim JJ, Park GS, Oh SM, Han CS, Lee MY. The antifungal activity of bee venom against dermatophytes. J Appl Biol Chem. 2012;55(1):7-11. crossref(new window)

Seoung IW. Antifungal activity of the extracts from Galla rhosis against Candida albicans. Korean J Med Mycol. 2007;12(4):175-9.

Seoung IW. Antifungal activity of the extracts from Paeonia japonica against Candida albicans. Korean J Med Mycol. 2006;11(1):19-26.